Article Information
vol. 3 no. 84 84ra43
- Received for publication February 9, 2011
- Accepted for publication May 5, 2011
- .
Author Information
- Jasvinder K. Atwal1,
- Yongmei Chen2,
- Cecilia Chiu2,
- Deborah L. Mortensen3,
- William J. Meilandt1,
- Yichin Liu4,
- Christopher E. Heise4,
- Kwame Hoyte5,
- Wilman Luk5,
- Yanmei Lu5,
- Kun Peng6,
- Ping Wu7,
- Lionel Rouge7,
- Yingnan Zhang8,
- Robert A. Lazarus8,
- Kimberly Scearce-Levie1,
- Weiru Wang7,
- Yan Wu2,
- Marc Tessier-Lavigne1 and
- Ryan J. Watts1,*
- 1Neurodegeneration Labs, Department of Neuroscience, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.
- 2Department of Antibody Engineering, Genentech, South San Francisco, CA 94080, USA.
- 3Department of Pharmacokinetic and Pharmacodynamic Sciences, Genentech, South San Francisco, CA 94080, USA.
- 4Department of Biochemical Pharmacology, Genentech, South San Francisco, CA 94080, USA.
- 5Department of Assay and Automation Technology, Genentech, South San Francisco, CA 94080, USA.
- 6Department of BioAnalytical Research and Development, Genentech, South San Francisco, CA 94080, USA.
- 7Department of Structural Biology, Genentech, South San Francisco, CA 94080, USA.
- 8Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94080, USA.
- *↵To whom correspondence should be addressed. E-mail: rwatts{at}gene.com